Ticker Details
Lexicon Pharmaceuticals, Inc. Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company mainly designs and develops drugs for therapeutic areas.
IPO Date:	June 23, 2000
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$999.44M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.15 | 3.99%
Avg Daily Range (30 D):	$0.07 | 3.26%
Avg Daily Range (90 D):	$0.06 | 3.33%

Institutional Daily Volume
Avg Daily Volume:	1.15M
Avg Daily Volume (30 D):	2.71M
Avg Daily Volume (90 D):	2.6M

Trade Size
Avg Trade Size (Sh.):	263
Avg Trade Size (Sh.) (30 D):	220
Avg Trade Size (Sh.) (90 D):	258

Institutional Trades
Total Institutional Trades:	1,026
Avg Institutional Trade:	$1.55M
Avg Institutional Trade (30 D):	$4.41M
Avg Institutional Trade (90 D):	$3.96M
Avg Institutional Trade Volume:	.23M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.41M
Avg Closing Trade (30 D):	$8.37M
Avg Closing Trade (90 D):	$7.64M
Avg Closing Volume:	253.67K

News

Jun 3, 2026 @ 12:00 PM Lexicon to Present Data at the American Diabetes A... Source: Lexicon Pharmaceuticals, Inc.

May 14, 2026 @ 5:50 PM Navigating Life with Hypertrophic Cardiomyopathy Source: Michael French

Apr 17, 2026 @ 12:00 PM Lexicon to Present Data at the American Academy of... Source: Na

Feb 6, 2026 @ 10:17 PM Lexicon Announces Closing of Approximately $94.6 M... Source: Na

Feb 6, 2026 @ 10:17 PM Lexicon Announces Closing of Approximately $94.6 M... Source: Globe Newswire

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.07	$	$-.04
Diluted EPS	$-.07	$	$-.04
Revenue	$69.64M	$21.1M	$5.49M
Gross Profit	$69.29M	$20.99M	$5.29M
Net Income / Loss	$-26.09M	$-1.04M	$-15.53M
Operating Income / Loss	$-24.23M	$-1M	$-14.78M
Cost of Revenue	$.35M	$.11M	$.2M
Net Cash Flow	$4.2M	$3.76M	$-15.33M
PE Ratio

Splits
May 21, 2015	1:7